Protein modifications key influencers in neurodegenerative diseases Research EPFL Exploring the post-translational modifications of a key protein in Parkinson's disease, researchers at EPFL and USC uncover potential pathways for future therapies in neurodegenerative diseases in general. “Genomic time machine” reveals secrets of our DNA Research EPFL EPFL researchers reveal a novel method to uncover bits of our genetic blueprint that come from ancient genetic parasites, offering fresh insights into human evolution and health. Methods for bypassing and treating spinal cord injury TechTransfer EPFL Grégoire Courtine, Jocelyne Bloch and their research team have been breaking new ground in the treatment of neurological disorders for over a decade. Here’s a look at some of the promising new therapies they’ve developed. How bacterial cords spread tuberculosis Research EPFL A groundbreaking study reveals how Mycobacterium tuberculosis forms resilient cords within host cells, opening the way for a deeper understanding and innovative treatment of tuberculosis. Molecular cooperation at the threshold of life Research ETH Zurich Protein-like aggregates known as amyloids can bind to molecules of genetic material. It is possible that these two types of molecules stabilised each other during the development of life – and that this might even have paved the way for the genetic code. How the COVID-19 virus makes itself more infectious Research EPFL Scientists at EPFL have uncovered a cunning strategy that SARS-CoV-2, the virus that causes COVID-19, uses to increase its infectivity. Previous 1 2 3 4 5 6 7 8... Next Page 4 of 16
